CBD meets diabetes drugs: could this combo be a game changer for weight and sugar?
Disease control
Completed
This early-phase study tested a special form of cannabidiol (CBD) called DehydraTECH, alone or combined with GLP-1 drugs (like Ozempic), in 148 overweight or obese adults with prediabetes or type 2 diabetes. The main goal was to check safety and how the body processes the drugs, …
Phase: PHASE1 • Sponsor: Lexaria Bioscience Corp. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC